Pablo Garcia-Pavia


Dr García-Pavia combines his activity as group leader of Inherited Cardiomyopathis at CNIC with being the director of the Heart Failure and Inherited Cardiac Diseases Unit  at the Department of Cardiology of Hospital Universitario Puerta de Hierro  in Madrid, Spain. The Unit is designed as national reference unit (CSUR) for inherited cardiovascular diseases by the Spanish Ministry of Health and also acts as a European reference center for rare cardiovascular diseases after its designation in 2017 by the European Commission. Apart of his work at Hospital Puerta de Hierro, he is also the leader of the Inherited Cardiac Disease Program at the CIBERCV, the Spanish collaborative research infrastructure that joins the 40 leading Spanish cardiovascular research groups and is Associate editor of Revista Española de Cardiología.

His areas of research include heart failure, amyloidosis, and cardiomyopathies. After finishing his training in Cardiology in Madrid, Dr Garcia-Pavia completed a clinical research fellowship at the Inherited Cardiovascular Diseases Unit at The Heart Hospital (University College of London) in London, UK. Previously he had undertaken short stays as research fellow in basic research labs focused in genetics at the University of Chicago, Complutense University and Autonoma University.

Dr Garcia-Pavia is the leader of the 2021 ESC position paper on diagnosis and treatment of cardiac amyloidosis and serves in the steering committee of several ongoing clinical trials in TTR cardiac amyloidosis and genetic DCM. He is also former member of ESC Council on Basic Research, former member of the Nucleus of ESC working group on myocardial and pericardial diseases, and former president of Spanish Society of Cardiology’s working group on inherited cardiac diseases. He has published >190 articles in peer-reviewed journals including European Heart Journal, J Am Coll Cardiol, Circulation, Nature Communications, Nature Medicine and The Lancet.